{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:25:22Z","timestamp":1761546322013,"version":"build-2065373602"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Amelogenin, used as a periodontal tissue regeneration material, promotes healing after periodontal surgery. A previous study has demonstrated that amelogenin is taken up by macrophages into the nucleus and inhibits major histocompatibility class II (MHC II) expression at the transcriptional level, thereby suppressing subsequent T cell activation. Therefore, in this study, we focused on the suppressive effect of amelogenin on MHC II expression and examined the effect of amelogenin on graft rejection following allogeneic skin transplantation in mice with different MHC II haplotype antigens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      Skin grafts were treated with recombinant murine amelogenin (rM180) and transplanted into recipient mice. The rM180-treated group showed a significant increase in graft survival for up to 5.5 days and a lower necrotic score than the control group. Inflammatory cell infiltration and MHC II\n                      <jats:sup>+<\/jats:sup>\n                      cells were significantly lower in the rM180 group. Furthermore, serum interferon-\u03b3, interleukin-2, and interleukin-17A levels, splenic T-helper type 1 cells and helper type 17\/regulatory T cells balance were reduced in the rM180 group. RNA sequencing analysis suggested \"negative regulation of immune response\" and \"regeneration of myocytes and myofibrils\" by amelogenin treatment. Among the upregulated genes in the rM180 group,\n                      <jats:italic>\u201cPOU domain class 2 transcription factor 2,\u201d \u201clipocalin 2,\u201d<\/jats:italic>\n                      and\n                      <jats:italic>\u201cchitinase-like 4\u201d<\/jats:italic>\n                      were ranked high. Additionally, the ratio of M2 macrophages significantly increased in rM180-treated grafts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These results may suggest that amelogenin can be a safe immunosuppressant or therapeutic agent against autoimmune diseases without inducing unfavorable side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1663437","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:20:20Z","timestamp":1761546020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolonged skin allograft survival by rM180 amelogenin in a murine skin transplantation model"],"prefix":"10.3389","volume":"16","author":[{"given":"Miyu","family":"Shida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terukazu","family":"Sanui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Yotsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mwannes","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaharu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusanori","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2011.06.005","article-title":"Epidemiology of burns throughout the world. Part I: Distribution and risk factors","volume":"37","author":"Peck","year":"2011","journal-title":"Burns"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3181bf8413","article-title":"Composite tissue allotransplantation","volume":"124","author":"Siemionow","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.042","article-title":"From immunosuppression to tolerance","volume":"62","author":"Adams","year":"2015","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1391","article-title":"A peptide\u2019s perspective on antigen presentation to the immune system","volume":"9","author":"Neefjes","year":"2013","journal-title":"Nat Chem Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1461328","article-title":"Bioengineered skin substitutes and immune tolerance strategies","volume":"12","author":"Dean","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001234","article-title":"Regenerative approaches to skin repair: minimizing immunosuppression","volume":"36","author":"Mahajan","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60699-5","article-title":"Diagnosis and prevention of chronic kidney allograft loss","volume":"378","author":"Nankivellers","year":"2011","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s007840050127","article-title":"Emdogain\u2013periodontal regeneration based on biomimicry","volume":"4","author":"Gestrelius","year":"2000","journal-title":"Clin Oral Investig"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fdmed.2025.1611402","article-title":"Research progress of enamel matrix derivative on periodontal tissue regeneration: a narrative review","volume":"6","author":"Xiang","year":"2025","journal-title":"Front Dent Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2008.01295.x","article-title":"Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration","volume":"35","author":"Sculean","year":"2008","journal-title":"J Clin Periodontol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2004.75.8.1150","article-title":"A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: Study design and results for primary outcomes","volume":"75","author":"Jepsen","year":"2004","journal-title":"J Periodontol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-009-3952-5","article-title":"Amelogenin is phagocytized and induces changes in integrin configuration, gene expression and proliferation of cultured normal human dermal fibroblasts","volume":"21","author":"Almqvist","year":"2010","journal-title":"J Mater Sci Mater Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4236\/ajmb.2017.72009","article-title":"Microarray analysis of the effects of amelogenin on U937 monocytic cells","volume":"7","author":"Sanui","year":"2017","journal-title":"Am J Mol Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00709","article-title":"Amelogenin downregulates interferon gamma-induced major histocompatibility complex class II expression through suppression of euchromatin formation in the class II transactivator promoter IV region in macrophages","volume":"11","author":"Yotsumoto","year":"2020","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0009-z","article-title":"Delayed allogeneic skin graft rejection in CD26-deficient mice","volume":"16","author":"Zhao","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00080.2021","article-title":"Comprehensive review of lipocalin 2-mediated effects in lung inflammation","volume":"321","author":"Guardado","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1038\/ncomms5088","article-title":"Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2","volume":"5","author":"Miao","year":"2014","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2962","article-title":"All known in vivo functions of the Oct-2 transcription factor require the C-terminal protein domain","volume":"172","author":"Corcoran","year":"2004","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600557113","article-title":"Regulation of normal B-cell differentiation and Malignant B-cell survival by Oct2","volume":"113","author":"Hodson","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02196\u201308","article-title":"Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi\u2019s sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma","volume":"83","author":"Di Bartolo","year":"2009","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46237-2","article-title":"IL-4 and IL-13 induce equivalent expression of traditional M2 markers and modulation of reactive oxygen species in human macrophages","volume":"13","author":"Scott","year":"2023","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e74690","DOI":"10.7554\/eLife.74690","article-title":"Macrophage innate training induced by IL-4 and IL-13 activation enhances OXPHOS driven anti-mycobacterial responses","volume":"11","author":"Lundahl","year":"2022","journal-title":"eLife"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.042","article-title":"Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression","volume":"40","author":"Mantovani","year":"2004","journal-title":"Eur J Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0504272","article-title":"Functional plasticity of macrophages: reversible adaptation to changing microenvironments","volume":"76","author":"Stout","year":"2004","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13702","article-title":"Immune exhaustion and transplantation","volume":"16","author":"Sanchez-Fueyo","year":"2016","journal-title":"Am J Transplant"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.6.3136","article-title":"Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo","volume":"165","author":"Smith","year":"2000","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v22.i4.50","article-title":"Role of IFN-gamma in allograft rejection","volume":"22","author":"Hidalgo","year":"2002","journal-title":"Crit Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.117","article-title":"Interleukin-2: a double-edge sword in allogeneic stem cell transplantation","volume":"8","author":"Avni","year":"2016","journal-title":"Immunotherapy"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.225","article-title":"IFN-\u03b3 dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses","volume":"182","author":"Coley","year":"2009","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1113560","article-title":"The immunomodulation role of Th17 and Treg in renal transplantation","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4285\/ctr.24.0058","article-title":"Targeting T helper 17 cells: emerging strategies for suppressing allograft rejection","volume":"38","author":"Lee","year":"2024","journal-title":"Clin Transplant Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00746","article-title":"Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4\/IL-36R crosstalk","volume":"10","author":"Shao","year":"2019","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-071816-064559","article-title":"Lipocalin 2: an emerging player in iron homeostasis and inflammation","volume":"37","author":"Xiao","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e89497","DOI":"10.1371\/journal.pone.0089497","article-title":"Neutrophil gelatinase-associated lipocalin increases HLA-G(+)\/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC","volume":"9","author":"La Manna","year":"2014","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67911","article-title":"Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes","volume":"123","author":"Warszawska","year":"2013","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2017.08.005","article-title":"Amelogenin induces M2 macrophage polarisation via PGE2\/cAMP signalling pathway","volume":"83","author":"Yamamichi","year":"2017","journal-title":"Arch Oral Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117343","article-title":"Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P","volume":"385","author":"Saenz-Pipaon","year":"2023","journal-title":"Atherosclerosis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301289","article-title":"MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production","volume":"191","author":"Mok","year":"2013","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e78129","DOI":"10.1371\/journal.pone.0078129","article-title":"Identification of novel amelogenin-binding proteins by proteomics analysis","volume":"8","author":"Fukuda","year":"2013","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25087","article-title":"Grp78 is critical for amelogenin-induced cell migration in a multipotent clonal human periodontal ligament cell line","volume":"231","author":"Toyoda","year":"2016","journal-title":"J Cell Physiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29903","article-title":"Combined application of geranylgeranylacetone and amelogenin promotes angiogenesis and wound healing in human periodontal ligament cells","volume":"122","author":"Yamato","year":"2021","journal-title":"J Cell Biochem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-15-23","article-title":"Establishment of a quantitative PCR system for discriminating chitinase-like proteins: catalytically inactive breast regression protein-39 and Ym1 are constitutive genes in mouse lung","volume":"15","author":"Ohno","year":"2014","journal-title":"BMC Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"240ra276","DOI":"10.1126\/scitranslmed.3007096","article-title":"Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in mammalian lung fibrosis","volume":"6","author":"Zhou","year":"2014","journal-title":"Sci Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010091","article-title":"YKL-40 associates with renal recovery in deceased donor kidney transplantation","volume":"28","author":"Puthumana","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.0424","article-title":"Temporal gene expression profiles after focal cerebral ischemia in mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Aging Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63972-7","article-title":"Hyalinosis and Ym1\/Ym2 gene expression in the stomach and respiratory tract of 129S4\/SvJae and wild-type and CYP1A2-null B6, 129 mice","volume":"158","author":"Ward","year":"2001","journal-title":"Am J Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-004-0654-4","article-title":"Cellular expression of murine Ym1 and Ym2, chitinase family proteins, as revealed by in situ hybridization and immunohistochemistry","volume":"121","author":"Nio","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010417200","article-title":"A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin","volume":"276","author":"Chang","year":"2001","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010417200","article-title":"Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice","volume":"275","author":"Guo","year":"2000","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2005.20.4.579","article-title":"Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma","volume":"20","author":"Jeong","year":"2005","journal-title":"J Korean Med Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1159\/000097024","article-title":"Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model","volume":"142","author":"Zhao","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.10.7312","article-title":"Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation","volume":"177","author":"Greenlee","year":"2006","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200401169","article-title":"Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach","volume":"5","author":"Zhao","year":"2005","journal-title":"Proteomics"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1601-20.2021","article-title":"Chitinase-like protein Ym2 (Chil4) regulates regeneration of the olfactory epithelium via interaction with inflammation","volume":"41","author":"Wang","year":"2021","journal-title":"J Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s1846","article-title":"Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence","volume":"3","author":"Romanelli","year":"2008","journal-title":"Clin Interv Aging"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-6343.2009.01459.x","article-title":"Enamel matrix proteins; old molecules for new applications","volume":"12","author":"Lyngstadaas","year":"2009","journal-title":"Orthod Craniofac Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1663437\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:20:21Z","timestamp":1761546021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1663437\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2025.1663437"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1663437","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"article-number":"1663437"}}